JPS5791911A - Base solution for high-calorie transfusion - Google Patents

Base solution for high-calorie transfusion

Info

Publication number
JPS5791911A
JPS5791911A JP16646080A JP16646080A JPS5791911A JP S5791911 A JPS5791911 A JP S5791911A JP 16646080 A JP16646080 A JP 16646080A JP 16646080 A JP16646080 A JP 16646080A JP S5791911 A JPS5791911 A JP S5791911A
Authority
JP
Japan
Prior art keywords
base solution
5w25meq
25w75meq
glucose
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16646080A
Other languages
Japanese (ja)
Inventor
Koji Daigo
Munehiro Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KIYOUSEI SEIYAKU KK
KYOSEI SEIYAKU KK
Original Assignee
KIYOUSEI SEIYAKU KK
KYOSEI SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KIYOUSEI SEIYAKU KK, KYOSEI SEIYAKU KK filed Critical KIYOUSEI SEIYAKU KK
Priority to JP16646080A priority Critical patent/JPS5791911A/en
Publication of JPS5791911A publication Critical patent/JPS5791911A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: The titled base solution that contains glucose and electrolytes consisting of Na, K, Ca, Mg, P and Cl in a specific range with a pH more close to neutrality, thus causing no precipitation and having few chances to be contaminated by bacteria with good handleability.
CONSTITUTION: The titled base solution is prepared by sterilizing a solution containing 200W500g/l glucose, 25W75mEq/l Na, 25W75mEq/l K, 5W25mEq/l Ca, 5W25mEq/l Mg, 5W25mEq/l P and 25W75mEq/l Cl at 60W75°C and adjusting the pH to 5.0W5.5. The base solution causes no change with time, even when stored for a long period of time and meets the sterility test according to Pharmacopoeia of Japan, containing simultaneously both Ca and P in the same preparation and having a pH value close to that of blood. When necessary, sodium hydrogen sulfite, which is usually used as a discoloration preventive, may be added to prevent glucose from yellowing.
COPYRIGHT: (C)1982,JPO&Japio
JP16646080A 1980-11-25 1980-11-25 Base solution for high-calorie transfusion Pending JPS5791911A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16646080A JPS5791911A (en) 1980-11-25 1980-11-25 Base solution for high-calorie transfusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16646080A JPS5791911A (en) 1980-11-25 1980-11-25 Base solution for high-calorie transfusion

Publications (1)

Publication Number Publication Date
JPS5791911A true JPS5791911A (en) 1982-06-08

Family

ID=15831806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16646080A Pending JPS5791911A (en) 1980-11-25 1980-11-25 Base solution for high-calorie transfusion

Country Status (1)

Country Link
JP (1) JPS5791911A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916818A (en) * 1982-07-20 1984-01-28 Shimizu Seiyaku Kk Solution for fluid therapy by administration through vein
JPS63107932A (en) * 1986-10-24 1988-05-12 Keizo Fukunaga High concentration complex electrolyte injection solution
WO1996020719A3 (en) * 1994-12-30 1996-09-06 East And Midlothian Nhs Trust Body fluid replacement solution

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916818A (en) * 1982-07-20 1984-01-28 Shimizu Seiyaku Kk Solution for fluid therapy by administration through vein
JPS6363534B2 (en) * 1982-07-20 1988-12-07
JPS63107932A (en) * 1986-10-24 1988-05-12 Keizo Fukunaga High concentration complex electrolyte injection solution
WO1996020719A3 (en) * 1994-12-30 1996-09-06 East And Midlothian Nhs Trust Body fluid replacement solution

Similar Documents

Publication Publication Date Title
DE3370930D1 (en) Protracted-release microbiocidal articles containing microbiocides of relatively low water solubility
SE8402551L (en) CINNAMOYLMORANOLIN DERIVATIVES
NZ210275A (en) Modified hirudin and its antithrombin properties
FR2368270A1 (en) TABLET FOR CLEANING DENTAL PROSTHESIS OR OTHER SIMILAR APPARATUS, AND PROCESS FOR PREPARING THIS TABLET
MD1688F2 (en) Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection
WO1991008981A3 (en) Solutions for stabilizing hydrogen peroxide containing solutions
EP0320980A1 (en) Use of a kit for contact lens sterilization and method for contact lens sterilization
US20010033843A1 (en) Coloured ophthalmic product
JPS5791911A (en) Base solution for high-calorie transfusion
AU2234588A (en) Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects
ES8700828A1 (en) A procedure to inhibit the precipitation of calcium salts and magnesium of the hard waters in sterilizing and disinfectant solutions. (Machine-translation by Google Translate, not legally binding)
GR78622B (en)
ES482393A1 (en) Sterilization system
JPS5791912A (en) Concentrated electrolyte solution for intravenous nutrition transfusion
JPS56128711A (en) Glucose-electrolyte preparation for high-calorie transfusion
JPS5762218A (en) Ophthalmic solution
ATE126437T1 (en) USE OF DEPOGEN TO TREAT RESTRICTED BLOOD CIRCULATION.
Ludlow et al. Rapid sterilization of gutta-percha points after chairside contamination.
ZA899248B (en) Doxorubicin aqueous solutions
GR3029898T3 (en) Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy.
ES8301627A1 (en) A procedure for the preparation of a sterile, non-imitating and atoxic triamtherene aqueous solution. (Machine-translation by Google Translate, not legally binding)
CA2044072A1 (en) Method of disinfection of soft contact lenses